Where vaptans do and do not fit in the treatment of hyponatremia (Q38068780)

28 August 2017

1 reference

title

Where vaptans do and do not fit in the treatment of hyponatremia (English)

1 reference

28 August 2017

Anna J Jovanovich

1

1 reference

28 August 2017

Tomas Berl

series ordinal

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

19 December 2012

1 reference

28 August 2017

1 reference

28 August 2017

83

1 reference

28 August 2017

563-567

1 reference

28 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2012.402

28 August 2017

0 references

cites work

Mortality after hospitalization with mild, moderate, and severe hyponatremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Mortality associated with low serum sodium concentration in maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Vasopressin receptor antagonists for the treatment of hyponatremia: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Vasopressin receptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Reversal of transtentorial herniation with hypertonic saline

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Intravenous conivaptan for the treatment of hyponatraemia caused by the syndrome of inappropriate secretion of antidiuretic hormone in hospitalized patients: a single-centre experience.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Treating hyponatremia: damned if we do and damned if we don't

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Astrocytes are an early target in osmotic demyelination syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Minocycline protects against neurologic complications of rapid correction of hyponatremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

The role of the neutral amino acid transporter SNAT2 in cell volume regulation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Reinduction of hyponatremia to treat central pontine myelinolysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Treating profound hyponatremia: a strategy for controlled correction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Treatment of euvolemic hyponatremia in the intensive care unit by urea

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Does 'asymptomatic hyponatremia' exist?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Mild hyponatremia and risk of fracture in the ambulatory elderly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Hyponatremia associated with large-bone fracture in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Mild hyponatremia as a risk factor for fractures: The rotterdam study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Hyponatremia-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with furosemide

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Impact of solute intake on urine flow and water excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Oral tolvaptan is safe and effective in chronic hyponatremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Neurogenic disorders of osmoregulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Nephrogenic syndrome of inappropriate antidiuresis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Familial nephrogenic syndrome of inappropriate antidiuresis: dissociation between aquaporin-2 and vasopressin excretion.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2012.402

7 January 2021

Identifiers

DOI

10.1038/KI.2012.402

1 reference

Dimensions Publication ID

28 August 2017

0 references

1 reference